Physician profile
Eric J Ashman
NPI 1639160849
$660.73
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $267 · 2020: $242 · 2021: $107 · 2024: $45.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $275.98 | 2020-2021 | |
| Supernus Pharmaceuticals, INC. | $164.51 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $74.42 | 2019-2021 | |
| Eisai INC. | $63.75 | 2020-2024 | |
| Resmed Corp | $31.96 | 2019 | |
| Abbott Laboratories | $26.83 | 2019 | |
| Sunovion Pharmaceuticals INC. | $23.28 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Ashman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.